Efforts to enhance viral hepatitis services, long in the making, appear to be ramping up in recent months and years under a range of initiatives, from Ryan White HIV/AIDS Program (RWHAP) projects to collaboration and surveillance work being facilitated by other agencies. Below is a tidy summary.
- HRSA's HIV/AIDS Bureau released a Hepatitis C Prescriber Toolkit in 2019, a state-based directly on Hepatitis C treatment prescribing restrictions and coverage under various federal programs. Other HRSA-funded resources, accessible via the toolkit, include Patient Assistance Programs for Hepatitis C Medication Costs and the HIV/HCV Co-infection: An AETC National Curriculum, an update of guides developed by HRSA a decade or so ago. HRSA has also been investing funding in various hepatitis C and HIV care investigative work, including multiple RWHAP research and demonstration grants under the Special Projects of National Significance (SPNS): Curing Hepatitis C among People of Color Living with HIV (2017-2020) and Jurisdictional Approach to Curing Hepatitis C among HIV/HCV Coinfected People of Color (2016-2019). Insights are forthcoming.
See more on our Hepatitis topic page
- NASTAD recently convened a National HIV and Hepatitis Technical Assistance Meeting to support state health department collaboration on hepatitis efforts and, in their brief meeting recap, highlighted an upcoming CDC funding opportunity for state and local health departments, Hepatitis Prevention and Surveillance Cooperative Agreement (CDC-RFA-PS20-2009), expected to be released in early January 2020.
- At the national level, HHS's Hepatitis C Medicaid Affinity Group is in its third year and has added nine more states in collaborative work to "increase the number of Medicaid enrollees cured of hepatitis C.
See The Important Role of Substance Use Disorder Treatment Providers in Ending the HCV and HIV Epidemics, an HHS Viral Hepatitis Blog